S4933 Aseptic Abscess Syndrome Causing Repeat Liver Abscess in a Patient With Ulcerative Colitis

Introduction: Aseptic abscess syndrome (AAS) is a rare inflammatory disorder that can be associated with inflammatory bowel disease. AAS is characterized by circumscribed, PMN-rich, sterile lesions. The literature on AAS is limited. Case Description/Methods: An 18-year-old woman with ulcerative colitis and 1 prior liver abscess who presented for follow-up on a liver ultrasound suggestive of a new liver abscess. The patient was previously hospitalized in July for a liver abscess measuring 5.8 × 4.7 × 5.9 cm. The abscess was drained, and she completed 3 weeks of ciprofloxacin and metronidazole for antimicrobial therapy. Her body fluid cultures from the abscess remained negative. She presented for a follow-up liver ultrasound, where a new collection measuring 7.5 × 6.8 × 3.5 cm was noted. She denied any acute complaints on evaluation. She was previously on infliximab-dyyb infusions; however, she had missed several doses secondary to loss of insurance. Labs were significant for a white blood cell count of 4.97, alkaline phosphatase of 86, ALT <10 and AST 18, all within normal limits. C-reactive protein was 1.2, and Erythrocyte sedimentation rate was 98. Stool entamoeba histolytica was negative. Giardia antigen, cryptosporidium antigen, stool cultures were all negative. Stool calprotectin was 2260. Magnetic resonance imaging during her admission showed findings compatible with abscess interposed between the lateral aspect of the liver and abdominal wall measuring approximately 5.2 × 2.4 × 6.3 cm. She underwent percutaneous drainage with interventional radiology that yielded purulent drainage. Her drain output remained minimal at less than 50 cc throughout her hospitalization. Fungal, acid-fast bacilli, and bacterial culture from the abscess remained negative. She was initially started on piperacillin-tazobactam and metronidazole for coverage of an intra-abdominal abscess, however these were discontinued following negative cultures. She re-started her infliximab-dyyb therapy with no abscess recurrence at 3 months. Discussion: Aseptic abscess syndrome is a manifestation of systemic inflammatory conditions and is associated with inflammatory bowel disease. Diagnosis is made through aspiration of the abscess which typically yields sterile collections of neutrophils. Abscesses can occur in a variety of organs including the spleen, skin, liver, lymph nodes, and lungs. Because many patients with inflammatory bowel disease are on immunosuppression, each abscess should be considered infectious until proven otherwise.

Authors

Publication Details

Journal
The American Journal of Gastroenterology
Published
2025-10-01
DOI
https://doi.org/10.14309/01.ajg.0001147192.09893.90
Primary Topic
Pneumocystis jirovecii pneumonia detection and treatment
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

S4933 Aseptic Abscess Syndrome Causing Repeat Liver Abscess in a Patient With Ulcerative Colitis

Harriet Hughes, L. A. Healey, Shujaut Farooq, Katherine Glosemeyer
The American Journal of Gastroenterology
Pneumocystis jirovecii pneumonia detection and treatment
article

S4933 Aseptic Abscess Syndrome Causing Repeat Liver Abscess in a Patient With Ulcerative Colitis

Harriet Hughes, L. A. Healey, Shujaut Farooq, Katherine Glosemeyer
article en

Abstract

Introduction: Aseptic abscess syndrome (AAS) is a rare inflammatory disorder that can be associated with inflammatory bowel disease. AAS is characterized by circumscribed, PMN-rich, sterile lesions. The literature on AAS is limited. Case Description/Methods: An 18-year-old woman with ulcerative colitis and 1 prior liver abscess who presented for follow-up on a liver ultrasound suggestive of a new liver abscess. The patient was previously hospitalized in July for a liver abscess measuring 5.8 × 4.7 × 5.9 cm. The abscess was drained, and she completed 3 weeks of ciprofloxacin and metronidazole for antimicrobial therapy. Her body fluid cultures from the abscess remained negative. She presented for a follow-up liver ultrasound, where a new collection measuring 7.5 × 6.8 × 3.5 cm was noted. She denied any acute complaints on evaluation. She was previously on infliximab-dyyb infusions; however, she had missed several doses secondary to loss of insurance. Labs were significant for a white blood cell count of 4.97, alkaline phosphatase of 86, ALT <10 and AST 18, all within normal limits. C-reactive protein was 1.2, and Erythrocyte sedimentation rate was 98. Stool entamoeba histolytica was negative. Giardia antigen, cryptosporidium antigen, stool cultures were all negative. Stool calprotectin was 2260. Magnetic resonance imaging during her admission showed findings compatible with abscess interposed between the lateral aspect of the liver and abdominal wall measuring approximately 5.2 × 2.4 × 6.3 cm. She underwent percutaneous drainage with interventional radiology that yielded purulent drainage. Her drain output remained minimal at less than 50 cc throughout her hospitalization. Fungal, acid-fast bacilli, and bacterial culture from the abscess remained negative. She was initially started on piperacillin-tazobactam and metronidazole for coverage of an intra-abdominal abscess, however these were discontinued following negative cultures. She re-started her infliximab-dyyb therapy with no abscess recurrence at 3 months. Discussion: Aseptic abscess syndrome is a manifestation of systemic inflammatory conditions and is associated with inflammatory bowel disease. Diagnosis is made through aspiration of the abscess which typically yields sterile collections of neutrophils. Abscesses can occur in a variety of organs including the spleen, skin, liver, lymph nodes, and lungs. Because many patients with inflammatory bowel disease are on immunosuppression, each abscess should be considered infectious until proven otherwise.

The American Journal of GastroenterologyVol. 120(10S2)
Openalex Percentile: Top 49%
Pneumocystis jirovecii pneumonia detection and treatment
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.